Lenalidomide Medication Supply
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract involves the supply of Lenalidomide oral capsules in various dosage strengths ranging from 2.5mg to 25mg to support prime contractors on Department of Veterans Affairs pharmaceutical procurement projects. The selected provider is responsible for manufacturing or distributing the medication in the requested formulations and quantities, ensuring all products adhere to FDA standards for purity and dosage. A critical requirement for this contract is the mandatory FDA Risk Evaluation and Mitigation Strategy certification. Deliveries are organized by specific contract line item numbers 0001 through 0006. The opportunity is managed under the Department of Veterans Affairs Network Contract Office 22 with a response deadline of November 12, 2026.
General Info
Place of Performance
AZSet-Aside
Documents
This scope was carved out of 36C26227Q0083.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
6505--FY27 Lenalidomide BPA
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Veterans Affairs → 262-NETWORK Contract Office 22 (36C262)
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
